Search company, investor...


Founded Year




About Cephalon

Salmedix develops oncology drugs with an initial emphasis on hematologic cancers.

Headquarters Location

41 Moores Road

Frazer, Pennsylvania, 19355,

United States


Missing: Cephalon's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cephalon's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Cephalon

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cephalon is included in 1 Expert Collection, including Cancer.



4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

Cephalon Patents

Cephalon has filed 126 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Autoimmune diseases
patents chart

Application Date

Grant Date


Related Topics




Chromatography, Molecular biology, Biotechnology, Protein methods, Proteins


Application Date


Grant Date



Related Topics

Chromatography, Molecular biology, Biotechnology, Protein methods, Proteins



Latest Cephalon News

Fibromyalgia Treatment Market Watch: Spotlight On Cephalon, Eli Lilly, AbbVie, Astellas Pharma, AstraZeneca

Nov 2, 2022

News Provided By Share This Article Fibromyalgia Treatment Market Study PORTLAND, OR, UNITED STATE, November 2, 2022 / / -- Allied Market Research added new research on Global Fibromyalgia Treatment Market - Global Opportunity Analysis and Industry Forecast, 2022–2030. The Fibromyalgia Treatment market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key players involved in the study are Abbott, AbbVie, Astellas Pharma, AstraZeneca, Bayer AG, Boehringer Ingelheim, Cephalon, Inc., Eli Lilly, F. Hoffmann-La Roche, GlaxoSmithKline, Johnson & Johnson Services, Novartis, Pfizer Inc., Sanofi. Get Free Sample PDF of Fibromyalgia Treatment Market Report>>> Which market perspectives are enlightened in the Fibromyalgia Treatment market report? Executive Summary: It covers a summary of the most vital studies, the Worldwide Fibromyalgia Treatment market increasing rate, modest circumstances, market trends, drivers and problems as well as macroscopic pointers. Study Analysis: This covers major players, vital market segments, the scope of the products offered in the Fibromyalgia Treatment market, the years measured and the study points. Competitive Analysis: In this segment each player is screened based on a products, services, value, SWOT analysis, growth and other significant features. Geographic Analysis: This Fibromyalgia Treatment market report analyses data on the basis of production, sales, imports & exports, and key players in all regional markets. Fibromyalgia Treatment Market Segments and Sub-segments:: Major Key Players: Abbott, AbbVie, Astellas Pharma, AstraZeneca, Bayer AG, Boehringer Ingelheim, Cephalon, Inc., Eli Lilly, F. Hoffmann-La Roche, GlaxoSmithKline, Johnson & Johnson Services, Novartis, Pfizer Inc., Sanofi. Fibromyalgia Treatment Market Segmentation by Treatment Type: Symptomatic Treatment and Targeted Treatment Fibromyalgia Treatment Market Segmentation by Drug Class: Antidepressants, Anticonvulsants, Muscle Relaxants, and Analgesics Fibromyalgia Treatment Market Segmentation by Distribution Channel: Hospital Pharmacy, Drug Store, Retail Pharmacy, and Online Pharmacy Ask more about Fibromyalgia Treatment Market Report>>> Interpretative Tools Used in Market Analysis: The methodical tools including SWOT analysis, Porter’s five forces analysis, and investment return examination were used while breaking down the development of the key players performing in the market. Growth Indicators in the Market: This section of the report covers the indicators that contains mergers & acquisitions, R&D, new product development, joint ventures, and associations of leading participants working in the market. Key Questions Answered: Which are the major regions covered in Fibromyalgia Treatment Market report? Which is the leading revenue-generating region in Fibromyalgia Treatment Market? Which is the most influencing segment growing in the Fibromyalgia Treatment market report? What are the key trends in the Fibromyalgia Treatment market report? What is the total market value of Fibromyalgia Treatment market report? Table of Content Chapter Three: Production Market Analysis Chapter Four: Sales Market Analysis Chapter Five: Consumption Market Analysis Chapter Six: Production, Sales and Consumption Market Comparison Analysis Chapter Seven: Major Manufacturers Production and Sales Market Comparison Analysis Chapter Eight: Competition Analysis by Players Chapter Nine: Marketing Channel Analysis Chapter Ten: New Project Investment Feasibility Analysis Chapter Eleven: Manufacturing Cost Analysis Chapter Twelve: Industrial Chain, Sourcing Strategy and Downstream Buyers Thank you for reading the article, Regional reports like North America, Europe, Asia-Pacific, LAMEA are also available. About Us: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. David Correa

Cephalon Frequently Asked Questions (FAQ)

  • When was Cephalon founded?

    Cephalon was founded in 1987.

  • Where is Cephalon's headquarters?

    Cephalon's headquarters is located at 41 Moores Road, Frazer.

  • What is Cephalon's latest funding round?

    Cephalon's latest funding round is PIPE.

  • Who are the investors of Cephalon?

    Investors of Cephalon include aPriori Capital Partners, Federated Investors, Federated Equity Funds - Federated Kaufmann Fund, Diaz & Altschul Advisors, Sprout Group and 5 more.

  • Who are Cephalon's competitors?

    Competitors of Cephalon include Bird Rock Bio, Aphios, Achillion Pharmaceuticals, PhaseBio Pharmaceuticals, Pique Therapeutics and 13 more.

Compare Cephalon to Competitors

Sarossa Capital

Sarossa, formerly Antisoma, is an investment holding and management company whose principal activity is investment in and growth and development of businesses which present opportunities for value creation.


Glycotope is a biopharmaceutical company in glycomics and its application for development of biopharmaceuticals.

Celgen Biopharmaceuticals

Shanghai Celgen Biopharmaceutical is a bio-similar biopharmaceuticals drugs developer and manufacture in China mainly focused on Inflammation, Oncology and Metabolic Disease. Celgen's main product is a Monoclonal Antibody (MAB) called Etanercept a Generic version of Amgen's Enbrel used for the treatment of inflammatory conditions such as Rheumatoid arthritis, Juvenile rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis, Plaque psoriasis.

Oligomerix Logo

Oligomerix is a clinical-stage biotechnology company. It focuses on developing disease-modifying therapeutics for neurodegenerative diseases characterized by the aberrant tau protein, ranging from tauopathies such as progressive supranuclear palsy and frontotemporal dementia to Alzheimer’s disease. The firm serves clients in the healthcare sector. Oligomerix was founded in 2006 and is based in West Harrison, New York.


AM-Pharma is a biopharmaceutical company that focuses on the development of recombinant Alkaline Phosphatase for clinical use.

Aphios Logo

Biopharmaceutical company developing enabling technology platforms and enhanced natural therapeutics for certain infectious diseases, cancers and CNS disorders. Ehanced therapeutics include small molecules from medicinal plants and marine organisms, and improved drug delivery formulations of protein macromolecules and hydrophobic anticancer drugs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.